Neuro Emotional Technique (NET) is a psycho-emotional therapy based on the physiological foundations of stress-related responses. As discovered in the late 1970’s, emotional responses are composed of neuropeptides (amino acid chains) and their receptors, which lie on neurons and other cells of remote tissues in the body. The neuropeptides are ejected from the neuron and carry the encoded “information” to other sites within the body. These neuropeptides are in a category of neurochemicals known as Information Substances (IS). ISs are released at times of stress-related arousal and become attached to remotely-positioned neuroreceptors.

Market Analysis and Insights: Global Neuroendocrine Tumors (NETs) Treatment Market
The global Neuroendocrine Tumors (NETs) Treatment market was valued at US$ XX in 2020 and will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2022-2027.

Global Neuroendocrine Tumors (NETs) Treatment Scope and Market Size
The global Neuroendocrine Tumors (NETs) Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Neuroendocrine Tumors (NETs) Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.

Segment by Type
Somatostatin Analogs (SSAs)
Targeted Therapy
Other

Segment by Application
Hospitals
Clinics
Other

The Neuroendocrine Tumors (NETs) Treatment market is analysed and market size information is provided by regions (countries). Segment by Application, the Neuroendocrine Tumors (NETs) Treatment market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.

By Company
Advanced Accelerator Applications
AVEO Oncology
Boehringer Ingelheim International
Hutchison MediPharma Limited
IpsenPharma
Novartis AG
Pfizer, Inc
Progenics Pharmaceuticals